Literature DB >> 3125853

Modification of intracellular glucose metabolism in human skin fibroblast preincubated with p-chlorophenoxyisobutyrate.

T Nishide1, K Shirai, Y Saito, S Yoshida.   

Abstract

1. The effect of p-chlorophenoxyisobutyrate (CPIB) on glucose metabolism human skin fibroblasts was examined. 2. CPIB increased the incorporation of 2-deoxy-D-[U-14C]glucose into skin fibroblasts. 3. CPIB decreased [14C]CO2 production from D-[U-14C]glucose but did not affect pyruvate dehydrogenase activity. 4. CPIB reduced fatty acid oxidation activity and cholesterol synthesis but increased triglyceride synthesis. 5. These effects of CPIB were observed both in the presence and in the absence of insulin. 6. One possible mechanism of CPIB on reducing plasma glucose may be due to the increase of glucose incorporation into the cells and triglyceride synthesis in the cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125853      PMCID: PMC1386401          DOI: 10.1111/j.1365-2125.1987.tb03243.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).

Authors:  M M BEST; C H DUNCAN
Journal:  Am J Cardiol       Date:  1965-02       Impact factor: 2.778

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Effect of clofibrate on glucose tolerance in maturity onset diabetes.

Authors:  D Barnett; J G Craig; D S Robinson; M P Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.

Authors:  R W Fenderson; I Sekowski; C Mohan; S Deutsch; F Benjamin; P Samuel
Journal:  Am J Clin Nutr       Date:  1974-01       Impact factor: 7.045

6.  Putative mediators of insulin action: regulation of pyruvate dehydrogenase and adenylate cyclase activities.

Authors:  A R Saltiel; M I Siegel; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Effect of p-chlorophenoxyisobutyrate on the antilipolytic action of insulin and insulin binding in isolated adipocytes.

Authors:  C Ip; H M Tepperman; J Tepperman
Journal:  J Lipid Res       Date:  1976-01       Impact factor: 5.922

8.  Separation of lipid classes by thin-layer chromatography.

Authors:  V P Skipski; A F Smolowe; R C Sullivan; M Barclay
Journal:  Biochim Biophys Acta       Date:  1965-10-04

9.  Fatty acid oxidation of rat brain microvessels in hypertension, aging and experimental diabetes.

Authors:  N Morisaki; Y Saito; A Kumagai
Journal:  Atherosclerosis       Date:  1982-04       Impact factor: 5.162

10.  Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.

Authors:  C Ferrari; S Frezzati; M Romussi; A Bertazzoni; G P Testori; S Antonini; A Paracchi
Journal:  Metabolism       Date:  1977-02       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.